Results
1 -
10 of
90Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma, Journal of Neuro-Oncology Third-Generation TKIs (Axitinib, Tivozanib) in RCC: Enhanced Efficacy and Diminished Toxicity?, Renal Cell Carcinoma Sunitinib and Axitinib in Renal Cell Carcinoma, Renal Cell Carcinoma Axitinib (AG-013736), Small Molecules in Oncology Tyrosine Kinase Inhibitors: Sorafenib, Sunitinib, Axitinib, and Pazopanib, Renal Cell Carcinoma Nebenwirkungsmanagement von Tyrosinkinaseinhibitoren in der Urologie, Der Urologe